| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.0005 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.61 | 0.0003 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |